Valuation check: SIBN's profit margin is -6.85%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), SIBN shows a profit margin of -6.85%. That compares with -12.83% in the prior-year period — up 46.6% year over year. That is below the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SIBN's profit margin is now -6.85% (was -12.83%) — a 46.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether SI-BONE is outperforming or lagging.
The Healthcare sector average profit margin is about 14.34%. SI-BONE is at -6.85%, which is lower that average. That is roughly 147.8% below the sector mean. Use the comparison chart on this page to see how SIBN stacks up against individual peers as well.
That compares with -12.83% in the prior-year period — up 46.6% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare SI-BONE with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has SI-BONE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -6.85%) with ownership activity and broader fundamentals.